Implementation of AZD7442 (tixagevimab/cilgavimab) COVID-19 Pre-exposure Prophylaxis (prep) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient Groups.
INFECTIOUS DISEASES AND THERAPY（2024）
关键词
AZD7442,COVID-19,Immunocompromised,Israel,Pre-exposure prophylaxis,Real-world evidence,SARS-CoV-2,Tixagevimab/cilgavimab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要